Industry
Pharmaceuticals
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Pharmaceuticals
... Step Pharma today announced the closing of a Series A financing totalling (EURO)14.5 ...
... Inozyme Pharma, Mr. Jungles served as senior vice president, technical operations at Ultragenyx Pharmaceutical, vice president of contract manufacturing and supply chain at BioMarin Pharmaceuticals ...
... TORONTO, ONTARIO - TerrAscend Corp. (CSE: TER) ('TerrAscend' or the 'Company') is pleased to announce that it ...
... Cambridge, Massachusetts-based X4 Pharmaceuticals, a developer of novel CXCR4 inhibitor drugs to improve immune cell ...
... AmeriCann, Inc. (OTC: ACAN), Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF), AbbVie Inc. (NYSE: ABBV), and MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF). It's been ...
... to Acacia, he was Senior Vice President and Chief Commercial Officer of Cadence Pharmaceuticals from 2009 until its acquisition by Mallinckrodt Pharmaceuticals for $1.4 billion ...
... million investment in NeoPhore Ltd, a spin out from Cambridge, UK based PhoreMost Ltd. NeoPhore is focused on the discovery and development of novel small ...
... Inozyme Pharma, Inc., a biotechnology company developing novel medicines to treat rare diseases of ...
... Inozyme Pharma Inc, a developer of treatments for rare diseases of calcification, affecting soft ...
... he previously held positions in early oncology clinical development at Genzyme and AstraZeneca. About Deep-Primed(TM) Immune Cell TherapeuticsTorque's Deep-Priming platform is based on 10 years ...
... ArQule, Inc. (NASDAQ: ARQL) today announced the closing of a private placement with institutional ...
... happens in M&A. A little more than two years after Valeant bought Sprout Pharmaceuticals, the maker of so-called female Viagra pill Addyi, for $1 billion, ...
... California area. Since its inception, SiteOne has been dedicated to developing novel pain therapeutics and diagnostics to safely, effectively and efficiently treat acute and chronic ...
... Intel. This one will be a doozy to watch. FEMALE VIAGRA UPDATE: Valeant Pharmaceuticals will sell its female libido-pill business Sprout Pharmaceuticals back to its ...
... expected in 2018 - Clinicians are expecting registration of the product forthetreatmentofdRTA Advicenne, a late-stage pharmaceutical company focused on the development of pediatric-friendly therapeutics for ...
... major advertisers after allegations surfaced that employees were misleading clients. Bristol-Myers Squibb Co. (NYSE: BMY) will not renew its ad agreement for 2018 with the ...
... Exicure has pulled in more money to advance its pipeline of oligonucleotides. The ...
... NousCom, a Swiss oncology company, has closed its Series B funding round at ...
... immunotherapy AR101. And last month, the California biotech announced a deal with Regeneron to test its allergy medication in combination with Sanofi/Regeneron’s Dupixent (dupilumab). Its ...
... patent for that branded drug expires. That’s what’s about to happen to Pfizer, whose patent on Viagra doesn’t expire until 2020 but which struck a ...
... approval and promptly sold the company behind it for $1 billion to Valeant. Now, Whitehead has turned from entrepreneur to investor through her new venture ...
... Health Therapeutics Inc.'s (TSX VENTURE: EMH) (OTCQX: EMHTF) recent deal with Abattis Bioceuticals Corp. to acquire a controlling interest in Northern Vine Labs. The agreement ...
... announced today new support of US$2.64M for an ongoing partnership between Eisai Co., Ltd. (Eisai) and Medicines for Malaria Venture (MMV) to further develop compounds, ...
... US and European markets. "Now OviTex has attracted the interest of NASDAQ-listed Pacira Pharmaceuticals," Ward says. "Pacira will make an initial investment in TELA Bio ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤